Annual EBIT
-$546.46 M
+$526.00 K+0.10%
December 31, 2023
Summary
- As of February 7, 2025, SAGE annual earnings before interest & taxes is -$546.46 million, with the most recent change of +$526.00 thousand (+0.10%) on December 31, 2023.
- During the last 3 years, SAGE annual EBIT has fallen by -$1.17 billion (-187.58%).
- SAGE annual EBIT is now -187.58% below its all-time high of $623.97 million, reached on December 31, 2020.
Performance
SAGE EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$101.20 M
+$10.10 M+9.07%
September 30, 2024
Summary
- As of February 7, 2025, SAGE quarterly earnings before interest & taxes is -$101.20 million, with the most recent change of +$10.10 million (+9.07%) on September 30, 2024.
- Over the past year, SAGE quarterly EBIT has increased by +$10.10 million (+9.07%).
- SAGE quarterly EBIT is now -110.39% below its all-time high of $973.85 million, reached on December 31, 2020.
Performance
SAGE Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$372.46 M
+$77.05 M+17.14%
September 30, 2024
Summary
- As of February 7, 2025, SAGE TTM earnings before interest & taxes is -$372.46 million, with the most recent change of +$77.05 million (+17.14%) on September 30, 2024.
- Over the past year, SAGE TTM EBIT has increased by +$77.05 million (+17.14%).
- SAGE TTM EBIT is now -156.29% below its all-time high of $661.63 million, reached on June 30, 2021.
Performance
SAGE TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
SAGE EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +0.1% | +9.1% | +17.1% |
| 3 y3 years | -187.6% | +22.7% | -158.3% |
| 5 y5 years | -39.0% | +45.9% | +47.4% |
SAGE EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -18.6% | +0.1% | -139.3% | +43.2% | at high | +43.4% |
| 5 y | 5-year | -187.6% | +22.8% | -110.4% | +43.2% | -156.3% | +47.4% |
| alltime | all time | -187.6% | +22.8% | -110.4% | +45.9% | -156.3% | +47.4% |
Sage Therapeutics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$101.20 M(-9.1%) | -$372.46 M(-17.1%) |
| Jun 2024 | - | -$111.30 M(-5.4%) | -$449.51 M(-11.6%) |
| Mar 2024 | - | -$117.67 M(+178.3%) | -$508.67 M(-6.9%) |
| Dec 2023 | -$546.46 M(-0.1%) | -$42.29 M(-76.3%) | -$546.46 M(-17.0%) |
| Sep 2023 | - | -$178.25 M(+4.6%) | -$658.08 M(+5.9%) |
| Jun 2023 | - | -$170.46 M(+9.6%) | -$621.31 M(+7.3%) |
| Mar 2023 | - | -$155.47 M(+1.0%) | -$579.29 M(+5.9%) |
| Dec 2022 | -$546.99 M(+18.7%) | -$153.90 M(+8.8%) | -$547.02 M(+5.5%) |
| Sep 2022 | - | -$141.48 M(+10.2%) | -$518.61 M(+2.1%) |
| Jun 2022 | - | -$128.44 M(+4.3%) | -$508.02 M(+4.2%) |
| Mar 2022 | - | -$123.20 M(-1.8%) | -$487.60 M(+5.8%) |
| Dec 2021 | -$460.91 M(-173.9%) | -$125.49 M(-4.1%) | -$460.91 M(-172.2%) |
| Sep 2021 | - | -$130.89 M(+21.2%) | $638.42 M(-3.5%) |
| Jun 2021 | - | -$108.02 M(+11.9%) | $661.63 M(+0.4%) |
| Mar 2021 | - | -$96.51 M(-109.9%) | $659.09 M(+5.6%) |
| Dec 2020 | $623.97 M(-188.1%) | $973.85 M(-1004.3%) | $623.97 M(-219.0%) |
| Sep 2020 | - | -$107.69 M(-2.6%) | -$524.51 M(-13.2%) |
| Jun 2020 | - | -$110.56 M(-16.0%) | -$604.00 M(-9.8%) |
| Mar 2020 | - | -$131.62 M(-24.6%) | -$669.90 M(-5.4%) |
| Dec 2019 | -$708.12 M(+80.1%) | -$174.64 M(-6.7%) | -$708.12 M(+1.5%) |
| Sep 2019 | - | -$187.18 M(+6.1%) | -$697.71 M(+9.1%) |
| Jun 2019 | - | -$176.46 M(+3.9%) | -$639.28 M(+31.8%) |
| Mar 2019 | - | -$169.85 M(+3.4%) | -$484.97 M(+23.3%) |
| Dec 2018 | -$393.24 M | -$164.23 M(+27.6%) | -$393.24 M(+31.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2018 | - | -$128.75 M(+481.3%) | -$299.46 M(+22.2%) |
| Jun 2018 | - | -$22.15 M(-71.6%) | -$245.09 M(-16.6%) |
| Mar 2018 | - | -$78.12 M(+10.9%) | -$293.80 M(+7.6%) |
| Dec 2017 | -$273.15 M(+70.5%) | -$70.45 M(-5.3%) | -$273.16 M(+5.4%) |
| Sep 2017 | - | -$74.37 M(+5.0%) | -$259.08 M(+16.3%) |
| Jun 2017 | - | -$70.85 M(+23.3%) | -$222.78 M(+19.2%) |
| Mar 2017 | - | -$57.48 M(+2.0%) | -$186.93 M(+16.7%) |
| Dec 2016 | -$160.16 M(+69.2%) | -$56.38 M(+48.1%) | -$160.16 M(+21.0%) |
| Sep 2016 | - | -$38.06 M(+8.7%) | -$132.40 M(+11.8%) |
| Jun 2016 | - | -$35.01 M(+14.0%) | -$118.41 M(+9.2%) |
| Mar 2016 | - | -$30.71 M(+7.3%) | -$108.47 M(+14.6%) |
| Dec 2015 | -$94.65 M(+179.9%) | -$28.61 M(+18.8%) | -$94.65 M(+20.7%) |
| Sep 2015 | - | -$24.08 M(-3.9%) | -$78.40 M(+22.9%) |
| Jun 2015 | - | -$25.06 M(+48.3%) | -$63.79 M(+42.0%) |
| Mar 2015 | - | -$16.90 M(+36.7%) | -$44.92 M(+32.9%) |
| Dec 2014 | -$33.81 M(+85.0%) | -$12.36 M(+30.5%) | -$33.81 M(+24.5%) |
| Sep 2014 | - | -$9.47 M(+53.0%) | -$27.16 M(+22.3%) |
| Jun 2014 | - | -$6.19 M(+6.9%) | -$22.21 M(+7.4%) |
| Mar 2014 | - | -$5.79 M(+1.3%) | -$20.68 M(+13.1%) |
| Dec 2013 | -$18.28 M(+89.8%) | -$5.71 M(+26.5%) | -$18.28 M(+45.5%) |
| Sep 2013 | - | -$4.52 M(-2.9%) | -$12.56 M(+56.2%) |
| Jun 2013 | - | -$4.66 M(+37.4%) | -$8.04 M(+137.4%) |
| Mar 2013 | - | -$3.39 M | -$3.39 M |
| Dec 2012 | -$9.63 M | - | - |
FAQ
- What is Sage Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for Sage Therapeutics?
- What is Sage Therapeutics annual EBIT year-on-year change?
- What is Sage Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Sage Therapeutics?
- What is Sage Therapeutics quarterly EBIT year-on-year change?
- What is Sage Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Sage Therapeutics?
- What is Sage Therapeutics TTM EBIT year-on-year change?
What is Sage Therapeutics annual earnings before interest & taxes?
The current annual EBIT of SAGE is -$546.46 M
What is the all time high annual EBIT for Sage Therapeutics?
Sage Therapeutics all-time high annual earnings before interest & taxes is $623.97 M
What is Sage Therapeutics annual EBIT year-on-year change?
Over the past year, SAGE annual earnings before interest & taxes has changed by +$526.00 K (+0.10%)
What is Sage Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of SAGE is -$101.20 M
What is the all time high quarterly EBIT for Sage Therapeutics?
Sage Therapeutics all-time high quarterly earnings before interest & taxes is $973.85 M
What is Sage Therapeutics quarterly EBIT year-on-year change?
Over the past year, SAGE quarterly earnings before interest & taxes has changed by +$10.10 M (+9.07%)
What is Sage Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of SAGE is -$372.46 M
What is the all time high TTM EBIT for Sage Therapeutics?
Sage Therapeutics all-time high TTM earnings before interest & taxes is $661.63 M
What is Sage Therapeutics TTM EBIT year-on-year change?
Over the past year, SAGE TTM earnings before interest & taxes has changed by +$77.05 M (+17.14%)